Key points are not available for this paper at this time.
Variability in detection of MAP by PCR (0-100% in Crohn's disease and ulcerative colitis tissues) 8 and serological testing 37 (6) No evidence of mycobacterial cell wall by histochemical staining (7) No worsening of Crohn's disease with immunosuppressive agents or HIV infection (8) No documented cell mediated immune responses to MAP in patients with Crohn's disease 20 (9) No therapeutic response to traditional antimycobacterial antibiotics 23 MAP, Mycobacterium avium subspecies paratuberculosis; PCR, polymerase chain reaction; FISH, fluorescent in situ hybridisation; HIV, human immunodeficiency virus.
R. Balfour Sartor (Fri,) studied this question.